Lv41
430 积分 2025-07-21 加入
European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel
28天前
已完结
Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model
28天前
已完结
Long-term Oncological Outcomes for Patients with Non–muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin (BCG): A Comparative Analysis of Adequate Versus Inadequate BCG Treatment
28天前
已完结
EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin
28天前
已完结
Murine bladder carcinoma cells present antigen to BCG-specific CD4+ T-cells
1个月前
已关闭
Role of Th1 and Th2 cytokines in BCG-induced IFN-γ production: cytokine promotion and simulation of BCG effect
1个月前
已完结
Conventional and PD-L1-expressing Regulatory T Cells are Enriched During BCG Therapy and may Limit its Efficacy
1个月前
已完结
Preexisting BCG-Specific T Cells Improve Intravesical Immunotherapy for Bladder Cancer
1个月前
已完结
Murine gut epithelial cells present antigen to specific T cell hybridoma
1个月前
已关闭
Requirement of a Thymus Dependent Immune Response for Bcg-mediated Antitumor Activity
1个月前
已完结
皖公网安备34019202002308
